Colon-Moran, Winston
Baer, Alan
Lamture, Gauri
Stapleton, Jack T.
Fischer, Joseph W.
Bhattarai, Nirjal http://orcid.org/0000-0003-1798-8863
Article History
Received: 14 May 2021
Revised: 22 October 2021
Accepted: 26 October 2021
First Online: 11 November 2021
Competing interests
: JTS and NB have patents or provisional patents related to the use of HCV proteins as immunomodulatory agents. The authors have no additional financial interests. This potential conflict does not interfere with the requirement of free exchange of any materials used in studies published by the Journal and as recommended by the National Academy of Sciences.